Mindray to acquire a controlling stake in ShenKe Medical
SK will retain its own brand and be operated independently under its former management team. Mindray has no plans to change SK’s employee base. Mindray will also honor all of SK’s contracts as agreed upon prior to the acquisition and maintain SK’s current policies on sale and after-sale service.
Mindray will utilize its platform to support SK’s future development (including manufacturing, R&D, quality control, sale, HR management, etc) and combine with SK’s resources effectively. Mindray will work diligently with SK to help the company become China’s leading infusion and syringe pump manufacturer.
We believe that the collaboration between Mindray and SK will bring many synergies to both parties. We expect that the combined company will provide better products and services to our customers, broader development opportunities to our employees, and help SK establish a stronger position to compete in the market place.
Based in Shenzhen, China, SK is a leading infusion and syringe pump manufacturer in China, mainly engaged in R&D, design, manufacturing and sale of infusion and syringe pump. For more information, please visit http://www.sk-medical.cn.
March 1st, 2011
Open WeChat and Scan the QR code .Get the Webpage and Share on Moments.
Mindray Charms the 2018 AACC in Chicago2018-08-13
Mindray Showcased New Innovations at CMEF Spring 20182018-04-24
ECR 2018: Envision more with the insightful solution2018-03-05
Mindray shined at Arab Health & MEDLAB Dubai 20182018-02-09
Mindray launches BeneVision N1 for uninterrupted monitoring during intra and out-of-hospital patient transport2018-01-15